tolebrutinib
Jump to navigation
Jump to search
Indications
- non-relapsing secondary progressive multiple sclerosis
Adverse effects
- increases in serum ALT
Mechanism of action
- Bruton tyrosine kinase (BTK) inhibitor
More general terms
References
- ↑ George J Tolebrutinib Benefits Non-Relapsing Secondary Progressive Multiple Sclerosis. "The very first time we have identified a treatment that is effective for this form of MS" MedPage Today April 14, 2025 https://www.medpagetoday.com/meetingcoverage/aan/115108
ox RJ, Bar-Or A, Traboulsee A et al for the HERCULES Trial Group. Tolebrutinib in Nonrelapsing Secondary Progressive Multiple Sclerosis. N Engl J Med. 2025 Apr 8. PMID: https://pubmed.ncbi.nlm.nih.gov/40202696 https://www.nejm.org/doi/full/10.1056/NEJMoa2415988